跳至主要内容
临床试验/NCT02595606
NCT02595606Unknown4 期

0.3% Sodium Hyaluronate in the Treatment of Dry Eye of Diabetic Patients

Sun Yat-sen University1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2015年9月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
发起方
入组人数
60
试验地点
1
主要终点
ocular surface disease index

研究概览

简要总结

A randomized parallel controlled study was designed to compare the efficacy of 0.3% Sodium Hyaluronate in the treatment of Dry Eye of diabetic patients.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
17 Years 至 70 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • medical history of diabetes
  • diagnosed with proliferative diabetic retinopathy
  • diagnosed with dry eye
  • not involvement in other drug experiment in the past 2 weeks
  • vision acuity better than 0.1
  • no local drug using history or with at least 2 weeks blanking period

排除标准

  • allergy to any of the drug ingredient
  • being or going to be pregnant or in lactation period
  • with any other eye disease or other serious disease which might affect the trial or could not get in follow-up
  • with any eye surgery history in the past six months
  • usage of hormone for replacement therapy

研究组 & 干预措施

treatment group

Experimental

treatment with 0.3% Sodium Hyaluronate, by five times a day, one or two drop each time

干预措施: 0.3% Sodium Hyaluronate (Drug)

结局指标

主要结局

ocular surface disease index

时间窗: up to 2 months

pre-,1,4,8 weeks after the initiation of the study(the use of drug for experimental group)

次要结局

  • conjunctival goblet cells density(up to 2 months)
  • corneal fluorescein staining assessment(up to 2 months)
  • tear break up time(up to 2 months)
  • Schirmer' test(up to 2 months)

研究者

发起方
Sun Yat-sen University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Wang Zhichong

cornea department chief

Sun Yat-sen University

研究点 (1)

Loading locations...

相似试验